Ads
related to: ucla urology prostate cancer
Search results
Results From The WOW.Com Content Network
Belldegrun has written over 500 scientific publications related to urologic oncology and has authored several books on prostate and kidney cancers. [ 45 ] [ 46 ] He was one of the speakers at the Milken Institute Global Conference 2013, [ 47 ] delivered the keynote Andrew C. Novick Memorial Lecture at the Ninth International Kidney Cancer ...
Alexander Gershman is a Russian American surgeon (born on May 26, 1961, in Moscow, Russia.)He is considered one of the first surgeons in the world to apply the method of laparoscopic surgery and robotic-assisted surgery to urological surgery and is considered one of the world’s leading experts on minimally invasive surgery. [1]
Mark Scholz (born 1955) is a German-American, double board-certified oncologist and author. He serves as medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a medical practice exclusively focused on prostate cancer.
Arie S. Belldegrun, FACS; a director of the UCLA Institute of Urologic Oncology; Professor and Chief of Urologic Oncology at the David Geffen School of Medicine; [12] holds the Roy and Carol Doumani Chair in Urologic Oncology; [13] Clinical Director of the UCLA Prostate Disease Research Program; Surgical Director of the UCLA Kidney Cancer ...
Prostate cancer is a form of cancer that is typically slow-growing and originates in or on the prostate, a male reproductive gland that surrounds the urethra in proximity of the bladder and rectum. This is a result of malignant cells forming and multiplying at the prostate, which can then spread or metastasize to other organs in the body. [1]
The primary sponsor of the center is the Jonsson Cancer Center Foundation (JCCF), [2] a 501(c)(3) entity (established in 1945). [ 6 ] The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment ), education, research ( basic and clinical ), and cancer prevention .
Ads
related to: ucla urology prostate cancer